Literature DB >> 19942859

PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis.

Nabil Djouder1, Roland D Tuerk, Marianne Suter, Paolo Salvioni, Ramon F Thali, Roland Scholz, Kari Vaahtomeri, Yolanda Auchli, Helene Rechsteiner, René A Brunisholz, Benoit Viollet, Tomi P Mäkelä, Theo Wallimann, Dietbert Neumann, Wilhelm Krek.   

Abstract

The mobilization of metabolic energy from adipocytes depends on a tightly regulated balance between hydrolysis and resynthesis of triacylglycerides (TAGs). Hydrolysis is stimulated by beta-adrenergic signalling to PKA that mediates phosphorylation of lipolytic enzymes, including hormone-sensitive lipase (HSL). TAG resynthesis is associated with high-energy consumption, which when inordinate, leads to increased AMPK activity that acts to restrain hydrolysis of TAGs by inhibiting PKA-mediated activation of HSL. Here, we report that in primary mouse adipocytes, PKA associates with and phosphorylates AMPKalpha1 at Ser-173 to impede threonine (Thr-172) phosphorylation and thus activation of AMPKalpha1 by LKB1 in response to lipolytic signals. Activation of AMPKalpha1 by LKB1 is also blocked by PKA-mediated phosphorylation of AMPKalpha1 in vitro. Functional analysis of an AMPKalpha1 species carrying a non-phosphorylatable mutation at Ser-173 revealed a critical function of this phosphorylation for efficient release of free fatty acids and glycerol in response to PKA-activating signals. These results suggest a new mechanism of negative regulation of AMPK activity by PKA that is important for converting a lipolytic signal into an effective lipolytic response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19942859      PMCID: PMC2824464          DOI: 10.1038/emboj.2009.339

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.

Authors:  Reuben J Shaw; Katja A Lamia; Debbie Vasquez; Seung-Hoi Koo; Nabeel Bardeesy; Ronald A Depinho; Marc Montminy; Lewis C Cantley
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

2.  The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells.

Authors:  S K Moule; R M Denton
Journal:  FEBS Lett       Date:  1998-11-20       Impact factor: 4.124

3.  Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase.

Authors:  S A Hawley; M Davison; A Woods; S P Davies; R K Beri; D Carling; D G Hardie
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

4.  Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism.

Authors:  A J Garton; D G Campbell; D Carling; D G Hardie; R J Colbran; S J Yeaman
Journal:  Eur J Biochem       Date:  1989-01-15

5.  Identification of novel phosphorylation sites in hormone-sensitive lipase that are phosphorylated in response to isoproterenol and govern activation properties in vitro.

Authors:  M W Anthonsen; L Rönnstrand; C Wernstedt; E Degerman; C Holm
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

Review 6.  Metabolism of lipids in human white adipocyte.

Authors:  V Large; O Peroni; D Letexier; H Ray; M Beylot
Journal:  Diabetes Metab       Date:  2004-09       Impact factor: 6.041

7.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

8.  Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes.

Authors:  Marie Daval; Francine Diot-Dupuy; Raymond Bazin; Isabelle Hainault; Benoît Viollet; Sophie Vaulont; Eric Hajduch; Pascal Ferré; Fabienne Foufelle
Journal:  J Biol Chem       Date:  2005-05-03       Impact factor: 5.157

Review 9.  Cyclic AMP, PKA, and the physiological regulation of adiposity.

Authors:  G S McKnight; D E Cummings; P S Amieux; M A Sikorski; E P Brandon; J V Planas; K Motamed; R L Idzerda
Journal:  Recent Prog Horm Res       Date:  1998

10.  Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction.

Authors:  Kei Sakamoto; Afshan McCarthy; Darrin Smith; Kevin A Green; D Grahame Hardie; Alan Ashworth; Dario R Alessi
Journal:  EMBO J       Date:  2005-05-05       Impact factor: 11.598

View more
  119 in total

1.  Protein kinase A contributes to the negative control of Snf1 protein kinase in Saccharomyces cerevisiae.

Authors:  LaKisha Barrett; Marianna Orlova; Marcin Maziarz; Sergei Kuchin
Journal:  Eukaryot Cell       Date:  2011-12-02

2.  Augmenting energy expenditure by mitochondrial uncoupling: a role of AMP-activated protein kinase.

Authors:  Susanne Klaus; Susanne Keipert; Martin Rossmeisl; Jan Kopecky
Journal:  Genes Nutr       Date:  2011-12-04       Impact factor: 5.523

3.  AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.

Authors:  Benjamin R Nixon; Ariyoporn Thawornkaiwong; Janel Jin; Elizabeth A Brundage; Sean C Little; Jonathan P Davis; R John Solaro; Brandon J Biesiadecki
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

Review 4.  Energy dysfunction in Huntington's disease: insights from PGC-1α, AMPK, and CKB.

Authors:  Tz-Chuen Ju; Yow-Sien Lin; Yijuang Chern
Journal:  Cell Mol Life Sci       Date:  2012-05-25       Impact factor: 9.261

5.  Effects of atypical antipsychotics and haloperidol on PC12 cells: only aripiprazole phosphorylates AMP-activated protein kinase.

Authors:  Goro Takami; Miyuki Ota; Akira Nakashima; Yoko S Kaneko; Keiji Mori; Toshiharu Nagatsu; Akira Ota
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

Review 6.  The regulation of autophagy - unanswered questions.

Authors:  Yongqiang Chen; Daniel J Klionsky
Journal:  J Cell Sci       Date:  2011-01-15       Impact factor: 5.285

7.  p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake.

Authors:  Yossi Dagon; Elizabeth Hur; Bin Zheng; Kerry Wellenstein; Lewis C Cantley; Barbara B Kahn
Journal:  Cell Metab       Date:  2012-06-21       Impact factor: 27.287

Review 8.  AMP-activated protein kinase and its downstream transcriptional pathways.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

9.  An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.

Authors:  Maria Rohm; Michaela Schäfer; Victor Laurent; Bilgen Ekim Üstünel; Katharina Niopek; Carolyn Algire; Oksana Hautzinger; Tjeerd P Sijmonsma; Annika Zota; Dasa Medrikova; Natalia S Pellegata; Mikael Ryden; Agné Kulyte; Ingrid Dahlman; Peter Arner; Natasa Petrovic; Barbara Cannon; Ez-Zoubir Amri; Bruce E Kemp; Gregory R Steinberg; Petra Janovska; Jan Kopecky; Christian Wolfrum; Matthias Blüher; Mauricio Berriel Diaz; Stephan Herzig
Journal:  Nat Med       Date:  2016-08-29       Impact factor: 53.440

10.  Activation and inhibition of Snf1 kinase activity by phosphorylation within the activation loop.

Authors:  Rhonda R McCartney; Leopold Garnar-Wortzel; Dakshayini G Chandrashekarappa; Martin C Schmidt
Journal:  Biochim Biophys Acta       Date:  2016-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.